News

Video

Managing AEs in Cabo Nivo Combination Therapy for Advanced RCC

Expert oncologists discuss the nuances of managing toxicities associated with Cabozantinib and Nivolumab combination therapy for advanced renal cell carcinoma (RCC).

Related Videos
Amer Zeidan, MBBS, and Guillermo Garcia-Manero, MD, discuss current treatment trends in myelodysplastic syndromes.
Stephanie Graff, MD, and Chandler Park, FACP
Elias Jabbour, MD
Prithviraj Bose, MD, and Chandler Park, MD, FACP
Shubham Pant, MD, MBBS
Douglas W. Sborov, MD, MS
Chad Tang, MD
Elias Jabbour, MD, professor, Department of Leukemia, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center
Chad Tang MD, MD Anderson
Bora Lim, MD, MD Anderson